FDA Inspection 1035768 — Shivkamini Somasundaram, M.D.

Shivkamini Somasundaram, M.D. — FEI 3013934840

The FDA completed an inspection of Shivkamini Somasundaram, M.D. on Dec 18, 2017 in Westerville, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 18, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Westerville, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.